Skip to main content
Smart Investors Daily
Cardinal Health, Inc. logo

NASDAQ · CAH

Cardinal Health, Inc.

Healthcare · Medical - Distribution

$272.34

Down-$5.98 (-2.15%)

Updated Nov 20, 2026, 2:31 AM

SID Score

7.3/10

Composite research score

Smart Money

58/100

Neutral

Market cap
47.1B
P/E ratio
29.58
Dividend yield
0.93%
52-week range
$180.45 – $286.29
Volume
2.15M
Avg. volume
2.49M

Price performance · CAH

CAH price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

CAH closed at $272.34 after 21 trading sessions, up 6.53% for the selected period.

Last close
$272.34
Period change
+6.53%
Period low
$244.76
Period high
$283.85
Daily close
View OHLC price history
CAH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$276.20$279.74$271.27$272.342.15M
Nov 18, 2026$277.53$280.21$275.92$278.321.48M
Nov 17, 2026$281.13$284.63$279.00$279.251.85M
Nov 16, 2026$284.00$284.79$282.39$283.851.51M
Nov 13, 2026$280.09$281.87$276.75$281.101.26M
Nov 12, 2026$280.00$280.00$275.975$278.141.3M
Nov 11, 2026$275.45$277.76$274.74$277.45980.06K
Nov 10, 2026$274.34$278.065$272.83$276.791.6M
Nov 9, 2026$274.99$277.3826$272.32$274.291.38M
Nov 6, 2026$265.58$272.99$263.92$271.721.98M
Nov 5, 2026$274.54$286.29$267.61$267.823M
Nov 4, 2026$256.64$262.29$251.735$261.932.46M
Nov 3, 2026$252.91$256.51$252.91$252.941.68M
Nov 2, 2026$251.48$255.23$248.90$254.331.9M
Oct 30, 2026$255.02$259.84$250.12$250.481.95M
Oct 29, 2026$248.32$251.63$246.99$251.091.74M
Oct 28, 2026$243.91$247.14$243.49$244.761.1M
Oct 27, 2026$250.39$251.45$246.39$246.451.63M
Oct 26, 2026$250.50$254.37$249.955$251.541.69M
Oct 23, 2026$254.93$255.64$249.24$249.571.67M
Oct 22, 2026$258.21$259.21$254.82$255.641.5M

Latest CAH news

The latest Smart Investors Daily articles mentioning CAH.

CAH research

Overview

Company profile and research snapshot.

Company profile

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$211.22
Implied upside
—
Analysts
14
CAH recent ratings
DateFirmRatingTarget
Nov 18, 2026BarclaysOverweight—
Nov 17, 2026Wells FargoOverweight—
Nov 12, 2026Argus ResearchBuy—
Nov 10, 2026JP MorganNeutral—
Nov 9, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

Cardinal Health (CAH) Stock Could Be Pricey Following Raised Earnings Guidance

Cardinal Health has turned into one of the stronger long term performers in the healthcare distribution space. This puts fresh attention on whether the current share price lines up with what its earnings can support. After such a strong run, the key issue for you is whether the recent optimism baked into the stock is covered by the profit engine underneath. Over the past 5 years, Cardinal Health has delivered a very large cumulative return. This now makes the earnings power of the business...

Yahoo · Nov 11, 2026

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2027 to shareholders of record at the close of business on January 4, 2027.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.